Vara, a German medical technology company focused on breast cancer screening and detection, has announced its expansion to India. With a mission to improve the lives of women and their families through early detection of breast cancer, Vara will roll out its data-driven breast cancer screening solution with first screening centres in Mumbai through its partnership with Suburban Diagnostics and NM Medical.

Through these partnerships, Vara will offer screenings at affordable prices and raise awareness about the importance of breast cancer prevention and early detection.

Vara's technology combines Artificial Intelligence (AI) with digital mammography to detect breast cancer at its earliest stages. By using machine learning algorithms to analyse images and identify earliest signs of potential abnormalities, Vara's technology can improve the accuracy of breast cancer screening while reducing the number of unnecessary biopsies. Vara has published its approach and results in The Lancet, one of the most acclaimed medical publications globally, where it demonstrated that Vara-assisted radiologists significantly outperform average radiologists in detecting the earliest signs of breast cancer.

In addition to its breast cancer screening services, Vara also conducts awareness campaigns to educate women about breast cancer and the benefits of early detection. It also offers webinars and educational resources to healthcare providers and patients.

Vara is a CE-certified machine learning software platform that conforms to the highest quality standards globally. Vara’s expansion to India marks a significant milestone in the company’s mission to empower women with access to early breast cancer detection technologies.